Journal article
Association between timing of zoledronic acid infusion and hip fracture healing
Abstract
Patients in the Health Outcomes and Reduced Incidence with Zoledronic Acid Once Yearly (HORIZON) Recurrent Fracture Trial were assessed for evidence of delayed hip fracture healing. No association was observed between zoledronic acid (ZOL) and delayed healing. We conclude that ZOL has no clinically evident effect on fracture healing, even when the drug is infused in the immediate postoperative period.IntroductionIntravenous zoledronic acid 5 mg …
Authors
Colón-Emeric C; Nordsletten L; Olson S; Major N; Boonen S; Haentjens P; Mesenbrink P; Magaziner J; Adachi J; Lyles KW
Journal
Osteoporosis International, Vol. 22, No. 8, pp. 2329–2336
Publisher
Springer Nature
Publication Date
August 2011
DOI
10.1007/s00198-010-1473-1
ISSN
0937-941X
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AgedAged, 80 and overBone Density Conservation AgentsDiphosphonatesDouble-Blind MethodDrug Administration ScheduleFemaleFracture HealingFractures, UnunitedHip FracturesHumansImidazolesInfusions, IntravenousMaleMiddle AgedOsteoporotic FracturesPostoperative CarePostoperative PeriodRadiographyRisk FactorsZoledronic Acid